Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Holterman

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificityChenthamarakshan Vasu, Bellur S Prabhakar, Mark J Holterman
Autoimmunity|December 13, 2003
Modulation of dendritic cell function and cytokine production to prevent thyroid autoimmunityChenthamarakshan Vasu, Mark J Holterman, Bellur S Prabhakar
DNA and Cell Biology|May 23, 2002
CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHAVitaly Vasilevko, Anahit Ghochikyan, Mark J Holterman, et al.
The Surgical Clinics of North America|May 19, 2012
Pediatric obesityMark J Holterman, Ai-Xuan Le Holterman, Allen F Browne
International Immunology|April 17, 2003
Targeted engagement of CTLA-4 prevents autoimmune thyroiditisChenthamarakshan Vasu, Seema R Gorla, Bellur S Prabhakar, et al.
Journal of Pediatric Surgery|April 14, 2009
Persistent hypoglycemia in a child with a gastrocolic fistula--an unexpected presentation of leucine-sensitive hypoglycemiaDavid D Lee, Edward F Hollinger, Anthony W Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditisChenthamarakshan Vasu, Rukiye-Nazan E Dogan, Mark J Holterman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' diseaseRukiye-Nazan E Dogan, Chenthamarakshan Vasu, Mark J Holterman, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 21, 2010
New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetesYong Zhao, Brian Lin, Michael Dingeldein, et al.
Virus Research|August 22, 2006
Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptorsJoshua J Short, Chenthamarakshan Vasu, Mark J Holterman, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificityChenthamarakshan Vasu, Bellur S Prabhakar, Mark J Holterman
Autoimmunity|December 13, 2003
Modulation of dendritic cell function and cytokine production to prevent thyroid autoimmunityChenthamarakshan Vasu, Mark J Holterman, Bellur S Prabhakar
DNA and Cell Biology|May 23, 2002
CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHAVitaly Vasilevko, Anahit Ghochikyan, Mark J Holterman, et al.
The Surgical Clinics of North America|May 19, 2012
Pediatric obesityMark J Holterman, Ai-Xuan Le Holterman, Allen F Browne
International Immunology|April 17, 2003
Targeted engagement of CTLA-4 prevents autoimmune thyroiditisChenthamarakshan Vasu, Seema R Gorla, Bellur S Prabhakar, et al.
Journal of Pediatric Surgery|April 14, 2009
Persistent hypoglycemia in a child with a gastrocolic fistula--an unexpected presentation of leucine-sensitive hypoglycemiaDavid D Lee, Edward F Hollinger, Anthony W Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditisChenthamarakshan Vasu, Rukiye-Nazan E Dogan, Mark J Holterman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' diseaseRukiye-Nazan E Dogan, Chenthamarakshan Vasu, Mark J Holterman, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 21, 2010
New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetesYong Zhao, Brian Lin, Michael Dingeldein, et al.
Virus Research|August 22, 2006
Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptorsJoshua J Short, Chenthamarakshan Vasu, Mark J Holterman, et al.
Pageof 3